- Home
- ARVN vs JELD Comparison
ARVN vs JELD Comparison
Compare ARVN & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- JELD
- Stock Information
- Founded
- ARVN 2015
- JELD 1960
- Country
- ARVN United States
- JELD United States
- Employees
- ARVN N/A
- JELD N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- JELD Forest Products
- Sector
- ARVN Health Care
- JELD Basic Materials
- Exchange
- ARVN Nasdaq
- JELD Nasdaq
- Market Cap
- ARVN 456.2M
- JELD 316.5M
- IPO Year
- ARVN 2018
- JELD 2017
- Fundamental
- Price
- ARVN $7.53
- JELD $3.84
- Analyst Decision
- ARVN Buy
- JELD Hold
- Analyst Count
- ARVN 21
- JELD 8
- Target Price
- ARVN $20.53
- JELD $7.34
- AVG Volume (30 Days)
- ARVN 2.2M
- JELD 1.9M
- Earning Date
- ARVN 07-29-2025
- JELD 08-04-2025
- Dividend Yield
- ARVN N/A
- JELD N/A
- EPS Growth
- ARVN N/A
- JELD N/A
- EPS
- ARVN N/A
- JELD N/A
- Revenue
- ARVN $426,900,000.00
- JELD $3,592,472,000.00
- Revenue This Year
- ARVN $2.83
- JELD N/A
- Revenue Next Year
- ARVN N/A
- JELD $3.40
- P/E Ratio
- ARVN N/A
- JELD N/A
- Revenue Growth
- ARVN 498.74
- JELD N/A
- 52 Week Low
- ARVN $5.90
- JELD $3.27
- 52 Week High
- ARVN $34.11
- JELD $17.70
- Technical
- Relative Strength Index (RSI)
- ARVN 54.38
- JELD 42.69
- Support Level
- ARVN $6.70
- JELD $3.42
- Resistance Level
- ARVN $7.60
- JELD $4.06
- Average True Range (ATR)
- ARVN 0.45
- JELD 0.21
- MACD
- ARVN 0.15
- JELD 0.09
- Stochastic Oscillator
- ARVN 95.04
- JELD 71.52
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.